mianserin has been researched along with Clerambault Syndrome in 3 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine has demonstrated superior tolerability to the tricyclic antidepressants, primarily on account of its relative absence of anticholinergic, adrenergic and serotonin-related adverse effects." | 5.31 | Occurrence of mirtazapine-induced delirium in organic brain disorder. ( Bailer, U; Fischer, P; Kasper, S; Küfferle, B; Stastny, J, 2000) |
| "Two depressive patients with systemic lupus erythematosus (SLE) and cerebral infarction, while being treated with corticosteroid, are described." | 5.29 | Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. ( Abe, K; Mizuki, T; Ohji, T; Terao, T, 1994) |
| "Mirtazapine has demonstrated superior tolerability to the tricyclic antidepressants, primarily on account of its relative absence of anticholinergic, adrenergic and serotonin-related adverse effects." | 1.31 | Occurrence of mirtazapine-induced delirium in organic brain disorder. ( Bailer, U; Fischer, P; Kasper, S; Küfferle, B; Stastny, J, 2000) |
| "Two depressive patients with systemic lupus erythematosus (SLE) and cerebral infarction, while being treated with corticosteroid, are described." | 1.29 | Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. ( Abe, K; Mizuki, T; Ohji, T; Terao, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yeh, YW | 1 |
| Chen, CY | 1 |
| Kuo, SC | 1 |
| Wang, TY | 1 |
| Wang, HY | 1 |
| Chen, CL | 1 |
| Terao, T | 1 |
| Mizuki, T | 1 |
| Ohji, T | 1 |
| Abe, K | 1 |
| Bailer, U | 1 |
| Fischer, P | 1 |
| Küfferle, B | 1 |
| Stastny, J | 1 |
| Kasper, S | 1 |
3 other studies available for mianserin and Clerambault Syndrome
| Article | Year |
|---|---|
Mirtazapine treatment of periodic catatonia in organic mental disorder: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Catatonia; Humans; Male; Mianserin; Mirtazapine; Neurocogni | 2010 |
Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cerebral Infarction; Depressive Disorder; Dose-Response | 1994 |
Occurrence of mirtazapine-induced delirium in organic brain disorder.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Delirium; Depressive Disorder, Major; Fem | 2000 |